Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05050240 · ClinicalTrials.gov registry record · NA

BATokines as Biomarkers of Brown Fat in Humans

A NA study of Healthy Lifestyle, sponsored by Rockefeller University.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05050240: Active NA study of Healthy Lifestyle, sponsored by Rockefeller University.

NCT05050240 is a NA study of Healthy Lifestyle that is active but no longer recruiting, run by Rockefeller University. The registered enrollment target is 20 participants, below the 235-participant average among 16 other Healthy Lifestyle trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05050240, a NA study of Healthy Lifestyle, is active but no longer recruiting, sponsored by Rockefeller University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Brown adipose tissue (BAT) burns excess calories to produce heat in response to environmental cold. Rapidly growing evidence from rodent and human studies suggests that the presence and activation of brown fat are far more beneficial for whole body metabolism and cardiometabolic health than previously appreciated. Despite the clear associations between brown fat and metabolic health, we lack both: cost-effective means of detecting brown fat in humans as well as comprehensive insights into how brown fat facilitates metabolism on a molecular level in humans. Emerging evidence suggests that the benefits of brown fat activation are mediated, at least in part, by secretion of specific molecules into the bloodstream which signal to metabolically active organs such as skeletal muscle, liver and brain. A number of these so-called brown adipokines (or BATokines) have now been discovered in mice and shown to positively impact glucose homeostasis, liver and muscle function. Human deep-neck brown fat biopsies reveal that \>1000 molecules could potentially be secreted from brown fat, and \>400 are released by human brown fat cells in a dish, representing a major opportunity for discovery of high translational value. Here, we aim to identify a screen of first potential blood biomarkers of brown fat in healthy young humans. This will be achieved by analyzing plasma proteins in subjects with 'inactive brown fat' (warm) and 'activated brown fat' (3-hr cold exposure, cooling vests) using high-throughput technologies (SOMAscan and O-link) to identify temperature-sensitive brown fat-enriched molecules. This preliminary data will guide a larger follow up study in which we envision studying lean and obese (insulin sensitive and insulin resistant) subjects of various age groups and race/ethnicity. Human BATokines identified here will become primary targets for manipulation in experimental animals to assess their therapeutic potential against obesity, T2D, and associated diseases. Additi

Primary Outcome

Mass spectrometry generates a list of proteins for each sample. We will compare fold of change before and after cooling - a true change is defined as 1.5-fold.

Conditions Studied

Interventions

  • OTHER Cooling Vest Procedure
  • OTHER Fasting overnight

Study Locations (1)

New York

  • The Rockefeller University Hospital - New York

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-10-12
Est. Completion 2026-12-31
Phase NA
Rockefeller University

117 total trials

What the registry record for NCT05050240 still lists

NCT05050240 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 235-participant average among 16 other Healthy Lifestyle trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Healthy Lifestyle appearing as the primary indexed condition, and to 2 interventions - of which Cooling Vest Procedure is the first listed.

NCT05050240 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05050240 about?

NCT05050240 is a clinical study titled "BATokines as Biomarkers of Brown Fat in Humans". Brown adipose tissue (BAT) burns excess calories to produce heat in response to environmental cold. Rapidly growing evidence from rodent and human studies suggests that the presence and activation of brown fat are far more beneficial for whole body metabolism and cardiometabolic health than previous...

What is the current status of trial NCT05050240?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-10-12. Estimated completion is 2026-12-31.

What conditions does trial NCT05050240 study?

This clinical trial studies the following conditions: Healthy Lifestyle.

What interventions are being tested in trial NCT05050240?

The interventions under investigation include: Cooling Vest Procedure (OTHER), Fasting overnight (OTHER).

Who is sponsoring clinical trial NCT05050240?

This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05050240 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Lifestyle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05050240's enrollment target sits among peer trials

20 16th of 16 higher than 1 of 16 other Healthy Lifestyle trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Lifestyle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05050240, the US trial registry maintained by the National Library of Medicine. NCT05050240 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.